Condition · Skin / Connective Tissue
Collagen support
Evidence hub for collagen support and related biohacking interventions.
01
Evidence-ranked peptides
| Peptide | Use | Evidence |
|---|---|---|
| Relaxin 2 Relaxin 2 is an endogenous signalling peptide with established or emerging physiological relevance. | Collagen support insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| Palmitoyl Tripeptide 38 Palmitoyl Tripeptide 38 is used or marketed in cosmetic formulations, with evidence that is generally formulation-dependent and rarely peptide-isolated. | Collagen support insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| Relaxin Mimetic Relaxin Mimetic is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Collagen support insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
02
Current standard management
conventional medicineEvidence-based non-peptide options — including exercise, sleep, nutrition, physiotherapy and licensed medical treatments — often have stronger human evidence than research peptides.
Medical disclaimer —Standard-of-care information is educational only. Do not change or start treatment based on Atlas content. Always consult a qualified clinician for personal medical decisions.
04
Linked mechanisms
biological pathways discussed for this condition- Collagen synthesislimited
- Extracellular matrix remodellinglimited
- Relaxin family peptide receptor signallinglimited
- Nitric oxide / blood flowlimited
03
Community observations
No approved community reports for this condition yet. Submit one.
Clinician discussion
Questions you can ask a qualified clinician
- What are the established evidence-based options for this condition?
- What monitoring is appropriate before considering any experimental intervention?
- What long-term safety data exists for peptide-based approaches?
- Are there licensed medicines relevant to my situation?
↳